Le malattie neurodegenerative - Bibliografia

Le malattie neurodegenerative - Bibliografia


Torna alla pagina precedente

BIBLIOGRAFIA

[1] Kedar N. Prasad – Multiple antioxidants in the prevention and treatment of neurodegenerative disease – Current Opinion in Neurology 1999, 12: 761-70
[2] Michael Swash - Early diagnosis of ALS/MND - Journal of the Neurological Sciences 1998 160 S1: S33-36
[3] J. Karitzky et al – Imaging and neurochemical markers for diagnosis and disease progression in ALS - Journal of the Neurological Sciences 2001 191: 35-41
[4] Mark Mehler et al - Developmental mechanisms in the pathogenesis of neurodegenerative diseases - Progress in Neurobiology 2001 63: 337-63
[5] Andrew Eisen, Charles Krieger Amyotrophic Lateral Sclerosis Cambridge University Press 1998
[6] Catherine Rottkamp et al - Will antioxidant fulfill their expectations for the treatment of Alzheimer disease? – Mechanism of Aging and Development 2000 116: 169-79
[7] Paulsen JS, Zhao H, Stout JC, Guttman M, Shoulson I – Clinical markers of early disease in person near onset of Huntington’s disease – Neurology 2001 57: 658-62
[8] Jonathan Fallon: MPP+ produces progressive neuronal degeneration which is mediated by oxidative stress - Exp Neurol 1997 144: 193-198
[9] Forbes RB et al : Are the El Escorial and Revised El Escorial criteria for ALS reproducible? A study of inter-observer agreement. Neuron Disorder 2001 Sep; 2(3): 135-38
[10] Iwasaki Y et al The diagnostic pathway in amyotrophic lateral sclerosis – Neuron Disord 2001 Sep; 2(3): 123-26
[11] Walter G. Bradley et al H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis – Journal of the Neurological Sciences 169 (1999) 84-86
[12] Robert T. Malison et al Positron and single photon emission tomography - Neuropsycopharmacology: The fourth generation of progress
[13] Michael E. Phelps: Positron emission tomography provides molecular imaging of biological processes – PNAS 2000, 97: 9226-33
[14] Catherine Rottkamp et al - Will antioxidant fulfill their expectations for the treatment of Alzheimer disease? – Mechanism of Aging and Development 2000 116: 169-79
[15] Paulsen JS, Zhao H, Stout JC, Guttman M, Shoulson I – Clinical markers of early disease in person near onset of Huntington’s disease – Neurology 2001 57: 658-62
[16] Hitoshi Marita, Takeshi Hayashi, Tetsuro Marakami, Yasuhiro Manabe, Loji Abe Oxidative damage to mitochondrial DNA in spinal motoneurons of transgenic ALS mice - Molecular Brain Research 2001 89: 147-52
[17] A Law, S. Gauthier, R. Quirion – Say NO to Alzheimer’s disease: the putative link between NO and dementia of the AD type – Brain Research Reviews 2001 35: 73-96
[18] Tabner BJ, Turnbull S, El-Agnaf OM, Allsop D – Formation of hydrogen peroxide and hydroxyl radicals from Aβ and α-synuclein as a possible mechanism of cell death in AD and PD – Free Rad Biol Med 2002 32: 1076-83.
[19] J Karitzky, AC Ludolph – Imaging and neurochemical markers for diagnosis and disease progression in ALS – J. Neurological Sciences 2001 191: 35-41
[20] Seiji Kikuchi, Akihiko Ogata, Kazuyoshi Shimpo et al – Detection of an Amadori product, 1-hexitol-lysine, in the anterior horn of the ALS and SBMA spinal cord: evidence fora an early involvement of glycation in motoneuron disease – Acta Neuropathol 2000 99: 63-66
[21] Soledad Miranda, Carlos Opazo, Luis F. Larrondo, Ribaldo C. In estrosa – The role of oxidative stress in the toxicity induced by amyloid β-peptide in Alzeimer’s disease – Progress in Neurobiology 2000 62: 633-48
[22] Shoichi Sasaki,– Immunoreactivity of β-amyloid precursor protein in ALS – Acta Neuropathol 1999 97: 463-68
[23] Stefane Hunot, Andreas Hartmann, Etienne C. Hirsch – The inflammatory response in the Parkinson’s brain – Clinical Neuroscience Research 2001 1: 434-43
[24] Giuliano Preparata, Getullio Talpo, Emilio Del Giudice, Baldassarre Messina et al – The role of QED (Quantum Electro Dynamics) in medicine – Proceedings meeting 14.12.1999 Un. Roma la Sapienza
[25] Paolo Bellavite – Biodinamica – Tecniche Nuove
[26] Shashadhar Samal et al., Unaspected solute aggregation in water on diluition – Chem Comm 2001, 2224-25
[27] Paolo Bellavite Biodinamica – Tecniche Nuove 1998
[28] Y. Thomas, M. Schiff, L. Belkadi, P. Jurgens and J. Benveniste – Activation of human neutrophils by electronically transmitted phorbol-myristate avetate – Medical Hypoteses 2000 54: 33-39
[29] Smith C.W. Coherent electromagnetic fields and bio-communication 1989 – Urban and Swarzenberg, Munchen Smith C.W. Electromagnetic and magnetic vector potential bio-information and water–1994 Kluwer Acad. Publ. Dordrecht
[30] Popp F.A., Li KH, Gu Q. Recent Advances in biophotons research – 1992 World Scientific, Singapore
[31] Smith C.W. Electromagnetic effects in humans in: Biological coherence and response to external stimuli – Springer-Verlag, Berlin-Heidelberg 205-232
[32] Nuclear medicine and acupuncture message transmission. J Nucl Med. 1992 Mar;33(3):409-12.
[33] Davide Trotti, Niels C. Danbolt A. Volterra Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? – TiPS 1998 19: 328-334

Torna alla pagina precedente